medigraphic.com
SPANISH

Revista Cubana de Hematología, Inmunología y Hemoterapia

ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2015; 31 (2)

Evaluación de la concentración de hemoglobina en donantes regulares de plasma

Sánchez FP, Pérez ULE, Sánchez BMJ, González ÁM, Cuellar CY, García TD
Full text How to cite this article

Language: Spanish
References: 25
Page: 150-159
PDF size: 107.54 Kb.


Key words:

regular plasma donors, plasmapheresis, hemoglobin concentration, red blood cells mass loss.

ABSTRACT

Introduction: a close relation between repetitive whole blood donation and iron deficiency has been demonstrated, mainly depending on the frequency of donations. However, the possible effect on hemoglobin concentration that regular plasmapheresis could induce has been scarcely reported.
Objective: determine the behavior of this variant and to estimate red blood cell mass loss in intensive plasmapheresis donor level 2.
Methods: a longitudinal descriptive study was carried out reviewing medical records of 100 randomly selected donors to collect results of the determination of hemoglobin and hematocrit during a cycle of 24 donations. Red cell mass loss was estimated by measuring of volume and hematocrit of whole blood contained in the plasmapheresis set at the end of plasma donation and adding the total amount of blood collected for laboratory tests.
Results: average concentration of hemoglobin showed no statistically significant changes for both, female or male donors. The loss of red blood cell mass in a process of plasma was approximately 18 mL (9.25 mL remaining on the plasma set and 8.86 mL for laboratory tests) which was very close to the limit of 25 mL according to Centro para el Control Estatal de la Calidad de los Medicamentos en Cuba (CECMED) regulations.
Conclusions: even when hemoglobin and hematocrit concentration are easily estimated, sensitivity is not good for the evaluation of iron deficiency in periods in which only stores are diminished. The inclusion of other more precise laboratory tests will contribute to a better surveillance of haemoglobin levels in this group of individuals.


REFERENCES

  1. Centro para el Control Estatal de la Calidad de los Medicamentos. Regulación No.9-2006. Obtención de plasma humano mediante plasmaféresis productiva automatizada. La Habana: CECMED; 2006.

  2. OMS [Internet]. Blood Donor Selection. Guidelines on Assessing Donor Suitability for Blood. Ginebra: OMS; 2014. [Cited 2014 Jun 20] Available from: http://www.who.int/bloodsafety/publications/bts_guideline_donor_suitability/en/

  3. Exchange transfusion and haemapheresis. In: Klein HG, Anstee DJ. Mollison’s Blood Transfusion in Clinical Medicine. 11 ed. Massachusetts: Blackwell Publishing; 2009. p. 774-809.

  4. Smith JW. Blood Component Collection by Apheresis. In: Technical Manual. 17th ed. Bethesda: American Association of Blood Banks; 2008. p. 227-38.

  5. Dhingra N. Towards self-sufficiency in blood and blood products based on VNRD. Global Status, Challenges and Strategies. Geneva: WHO. 2013 [cited 2014 Jul 22]. Available from: http://www.fiods.org/main/sites/all/files/WHOGlobalStatus2013.pdf

  6. Bechtloff S, Tran-My B, Haubelt H, Stelzer G, Anders C, Hellstern P. A prospective trial on the safety of long-term intensive plasmapheresis in donors. Vox Sang. 2005 Apr;88(3):189-95.

  7. Tran-Mi B, Storch H, Seidel K, Schulzki T, Haubelt H, Anders C, et al. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers. Vox Sang. 2004 Apr;86(3):189-97.

  8. Schulzki T, Seidel K, Storch H, Karges H, Kiessig S, Schneider S, et al. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA). Vox Sang. 2006 Aug;91(2):162-73.

  9. Sánchez P, Sánchez MJ, García D, Mediaceja O. Comportamiento de proteínas séricas en donantes de plasmaféresis productiva. Medicentro [Internet]. 2009 [citado 16 ago 2014];13(1):[aprox. 10 p.]. Disponible en: http://www.medicentro.sld.cu/index.php/medicentro/article/view/328

  10. Mantilla CY, Cardona JA. Meta-análisis: prevalencia de deficiencia de hierro en donantes de sangre repetitivos y asociación con sexo, 2001-2011. Rev Cubana Hematol, Inmunol Hemoter. 2013;29(1):59-72.

  11. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron Deficiency in Blood Donors: Analysis of Enrollment Data from the REDS-II Donor Iron Status Evaluation (RISE) Study. Transfusion. 2011 Mar;51(3):511-22. doi: 10.1111/j.1537-2995.2010.02865.x.

  12. Bier-Ulrich AM, Haubelt H, Anders C, Nagel D, Schneider S, Siegler KE, et al. The impact of intensive serial plasmapheresis and iron supplementation on iron metabolism and Hb concentration in menstruating women: a prospective randomized placebo-controlled double-blind study. Transfusion. 2003 Mar;43(3):405-10.

  13. Fischer T, Surikova I, Heesen E, Wilms G, Laitinen T, Taborski U. Loss of red cell mass in a plasmapheresis machine: effect of rinsing the disposable tubing with normal saline and reinfusion. Transfus Apher Sci. 2013 Aug;49(1):80-3. doi: 10.1016/j.transci.2013.05.031.

  14. Means RT. Anemia: General considerations. In: Greer JP, Foerter J, Rodgers GM, Paraskevas F, Glader B, Arber B, et al. Wintrobe’s Clinical Hematology. 12 ed. Philadelphia: Lippincott Williams&Wilkins; 2009. p. 779-809.

  15. Campuzano Maya G. Anemia, un signo, no una enfermedad. 5 ed. Medellín: Edimeco; 2010.

  16. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014 Feb;19(2):164-74.

  17. Soto Matos J. Intervalos de Referencia, Hematología y Hemostasia. Red Cubana de Patología Clínica [Internet]. La Habana: Infomed; 1999-2014. [citado 18 jul 2014]. Disponible en: http://www.sld.cu/uvs/patologiaclinica/temas.php?idv=14631

  18. OPS. Elegibilidad para la donación de sangre. Recomendaciones para la educación y la selección de donantes potenciales de sangre. Washington: OPS; 2009.

  19. Ballester Santovenia JM, Alfonso Valdés ME, Ballester Planes L, Bencomo Hernández A, Cortina Rosales L, Macías Abraham C, et al. Procedimientos para bancos de sangre y servicios de transfusión. La Habana:Ciencias Médicas; 2009.

  20. Hematología [Internet]. La Habana: Infomed; 1999-2014. Criterios diagnósticos de anemia. [Citado 16 ago 2014]. Disponible en: http://articulos.sld.cu/hematologia/archives/1673

  21. Bryant JB, Hopkins AJ, Arceo MS, Leitman FS. Evaluation of low red blood cell mean corpuscular volume in an apheresis donor population. Transfusion. 2009 Sep;49(9):1971-6. doi: 10.1111/j.1537-2995.2009.02207.x.

  22. Dobao ML, Maia S, Mesquita P, Bessa M. Study of serum ferritinin donors of two red blood cells units collected by apheresis. Transfus Apher Sci. 2013 Oct;49(2):238-43. doi: 10.1016/j.transci.2013.06.001.

  23. Andrews NC. Iron deficiency and related disorders. In: Greer JP, Foerter J, Rodgers G M, Paraskevas F, Glader B, Arber B, et al. Wintrobe’s Clinical Hematology. 12 ed. Philadelphia: Lippincott Williams&Wilkins. 2009. p. 810–34.

  24. Pita G, Basabe CB, Jiménez CS, Mercader O. La anemia. Prevención por medio de la alimentación. La Habana: Instituto de Nutrición e Higiene de los Alimentos (INHA) 2007.

  25. Forrellat M, Hernández P, Fernández N, Pita G. ¿Se cumple siempre la relación hemoglobina hematócrito? Rev Cubana Hematol Inmunol Hemoter. 2010;26(4):359-61.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Hematol Inmunol Hemoter . 2015;31